首页> 外文期刊>AACN advanced critical care >Development and validation of a clostridium difficile risk assessment tool
【24h】

Development and validation of a clostridium difficile risk assessment tool

机译:艰难梭菌风险评估工具的开发和验证

获取原文
获取原文并翻译 | 示例
           

摘要

The incidence of Clostridium difficile infection has increased rapidly during the past decade, increasing lengths of stays in the hospital, costs, and mortality rates. To address this increased incidence, we performed a retrospective case-control study using known risk factors to develop a tool to determine which patients are at risk for infection. Multivariate analysis generated a combination of risk factors associated with development of infection including prior admission, endoscopy within 30 days, cephalosporin/fluoroquinolone use, length of stay 7 days or longer, age 65 years or older, body mass index less than 25, and albumin level less than 2.7 g/dL. A weighted scoring tool was created that predicted disease with a sensitivity of 86% and a specificity of 44% in the derivation sample, and 92% sensitivity and a specificity of 39% when applied to the validation sample. Application of this 8-item tool by nurses in multiple settings could aid in the determination of patients who are at risk, allowing prophylactic treatment, prompt isolation of patients, restricted antibiotic use, and decreased testing of lowrisk patients.
机译:在过去的十年中,艰难梭菌感染的发病率迅速增加,住院时间,费用和死亡率不断增加。为了解决这种增加的发病率,我们使用已知的危险因素进行了回顾性病例对照研究,以开发一种工具来确定哪些患者有感染风险。多变量分析综合了与感染发展相关的风险因素,包括事先入院,30天内进行内镜检查,使用头孢菌素/氟喹诺酮,住院时间超过7天,年龄65岁以上,体重指数低于25和白蛋白含量低于2.7 g / dL。创建了一个加权评分工具,可以预测疾病,在衍生样本中的敏感性为86%,特异性为44%,当应用于验证样本时,敏感性为92%,特异性为39%。护士在多种情况下使用此8件工具可以帮助确定有风险的患者,从而可以进行预防性治疗,及时隔离患者,限制使用抗生素并降低低危患者的检测水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号